Voice Technology-Based Self-Management Intervention
Launched by EMORY UNIVERSITY · May 13, 2025
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The Voice2Manage Intervention trial is studying a new program that uses voice-operated smart speakers to help older adults with mild cognitive impairment manage their health better. The program aims to teach participants how to use these devices for daily tasks, reminders, and scheduling, making it easier for them to take care of their chronic conditions. This is especially important for older adults living in low-income communities who may not have the resources or skills to use technology effectively.
To be eligible for this study, participants need to be 55 years or older, live in subsidized housing or have a low income, and have at least one chronic health condition. They should also have mild cognitive impairment and live independently. If chosen for the trial, participants will receive training on how to use the smart speakers and will be encouraged to engage in managing their health with this technology. It’s a great opportunity for those looking to improve their self-care skills with the support of new technology!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Persons 55 years of age and older,
- • Living in subsidized housing or with a housing voucher and having an annual income less than $30K,
- • One or more chronic conditions,
- • Having probable mild cognitive impairment (MCI), based on the education-adjusted Montreal Cognitive Assessment (MoCA) score less than 24 and greater than or equal to 18,
- • Living alone independently, and
- • Able to speak and read English.
- Exclusion Criteria:
- • Severe visual/hearing impairment requiring assistance in participating in interactions with the smart speaker and integrated devices,
- • Self-reported diagnoses of Alzheimer's disease and related dementias,
- • Significant medical illness interfering with the study assessments and activities,
- • Inability to provide informed consent, and
- • Nursing home residents.
- • Eligibility will not be limited to smart speaker ownership.
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Trial Officials
Jane Chung, PhD, RN
Principal Investigator
Emory University - Nell Hodgson Woodruff School of Nursing
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported